Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000950170-25-012101

Director acquired 17,950 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Johnson Craig A Director 2025-01-30 Grant or award +17,950 83,770 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Johnson Craig A Director 2025-01-30 Grant or award · Stock Option (Right to Buy) +35,900 $1.73 $62,107 35,900 D: show line 2 in the form
Loading xslF345X05/ownership.xml…